785134008: Bendamustine 100mg/4ml solution for infusion vials (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Bendamustine 100mg/4ml solution for infusion vials
\UK product\Virtual therapeutic moiety\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\UK product\Virtual therapeutic moiety\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials
\Medicinal product\Product manufactured as parenteral dose form\Product containing bendamustine in parenteral dose form (medicinal product form)\Product containing only bendamustine in parenteral dose form (medicinal product form)\Bendamustine 100mg/4ml solution for infusion vials

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3766234011 Bendamustine hydrochloride 100 mg powder for solution for injection vial en Synonym Active Entire term case insensitive SNOMED CT core module

3766235012 Product containing precisely bendamustine hydrochloride 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

2316601000001110 Bendamustine 100mg/4ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module

2316621000001115 Bendamustine 100mg/4ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendamustine 100mg/4ml solution for infusion vials	Has unit of presentation	Vial	false	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Has presentation strength numerator value	100	false	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Is a	Product containing only bendamustine in parenteral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has precise active ingredient	Bendamustine hydrochloride	true	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has basis of strength substance	Bendamustine hydrochloride	true	Inferred relationship	Existential restriction modifier	1
Bendamustine 100mg/4ml solution for infusion vials	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Is a	Bendamustine	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has specific active ingredient	Bendamustine hydrochloride	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Intravenous route	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Is a	Product containing bendamustine	false	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has dispensed dose form	Conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	solutioninfusion.intravenous ontology form and route	true	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials	Has manufactured dose form	Parenteral dose form	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendamustine 100mg/4ml concentrate for solution for infusion vials (Accord Healthcare Ltd)	Is a	True	Bendamustine 100mg/4ml solution for infusion vials	Inferred relationship	Existential restriction modifier
Bendamustine 100mg/4ml solution for infusion vials 5 vial	Has VMP	True	Bendamustine 100mg/4ml solution for infusion vials	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3766234011	Bendamustine hydrochloride 100 mg powder for solution for injection vial	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3766235012	Product containing precisely bendamustine hydrochloride 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
2316601000001110	Bendamustine 100mg/4ml solution for infusion vials (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module
2316621000001115	Bendamustine 100mg/4ml solution for infusion vials	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module